2024-516548-25-00CompletedPhase 1
A clinical study of MK-2420 in healthy people (MK-2420-002)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 2 Sept 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 23 Jan 2025
- Start date
- 12 Mar 2025
- Lead sponsor
- Merck Sharp & Dohme LLC
- EU CT number
- 2024-516548-25-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 40
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SGS Belgium | Edegem | Belgium | Completed |
| Universitair Ziekenhuis Gent | Gent | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.